REFERENCES
1. World Health Organization. Global status report on neurology. Available from: https://www.who.int/publications/i/item/9789240116139. [Last accessed on 22 May 2026].
2. Feigin VL, Vos T, Nichols E, et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19:255-65.
3. Furtado D, Björnmalm M, Ayton S, Bush AI, Kempe K, Caruso F. Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases. Adv Mater. 2018;30:e1801362.
4. Ying C, Zhang J, Zhang H, et al. Stem cells in central nervous system diseases: promising therapeutic strategies. Exp Neurol. 2023;369:114543.
5. Arbade G, Jose JV, Gulbake A, Kadam S, Kashte SB. From stem cells to extracellular vesicles: a new horizon in tissue engineering and regenerative medicine. Cytotechnology. 2024;76:363-401.
6. Zhang X, Che X, Zhang S, et al. Mesenchymal stem cell-derived extracellular vesicles for human diseases. Extracell Vesicles Circ Nucl Acids. 2024;5:64-82.
7. Yin T, Liu Y, He B, et al. Cell primitive-based biomimetic nanomaterials for Alzheimer’s disease targeting and therapy. Mater Today Bio. 2023;22:100789.
9. Choudhery MS, Arif T, Mahmood R, Harris DT. Stem cell-based acellular therapy: insight into biogenesis, bioengineering and therapeutic applications of exosomes. Biomolecules. 2024;14:792.
10. Shi M, Chu F, Zhu J. Stem cells therapy in neurodegenerative and neuroimmune diseases: current status of treatments and future prospects. Pharmacol Res. 2025;221:107960.
11. Yu S, Yu S, Liu H, Liao N, Liu X. Enhancing mesenchymal stem cell survival and homing capability to improve cell engraftment efficacy for liver diseases. Stem Cell Res Ther. 2023;14:235.
12. Su Z, Dong H, Fang X, Zhang W, Duan H. Frontier progress and translational challenges of pluripotent differentiation of stem cells. Front Genet. 2025;16:1583391.
13. Stahl PD, Raposo G. Extracellular vesicles: exosomes and microvesicles, integrators of homeostasis. Physiology. 2019;34:169-77.
15. Wang Y, Wang H, Tan J, et al. Therapeutic effect of mesenchymal stem cells and their derived exosomes in diseases. Mol Biomed. 2025;6:34.
16. Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7:1535750.
17. Welsh JA, Goberdhan DCI, O’Driscoll L, et al. ; MISEV Consortium. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13:e12404.
18. van Griensven M, Balmayor ER. Extracellular vesicles are key players in mesenchymal stem cells’ dual potential to regenerate and modulate the immune system. Adv Drug Deliv Rev. 2024;207:115203.
19. Pfrieger FW, Vitale N. Cholesterol and the journey of extracellular vesicles. J Lipid Res. 2018;59:2255-61.
20. Guevara-Olaya L, Chimal-Vega B, Castañeda-Sánchez CY, et al. LDL promotes disorders in β-cell cholesterol metabolism, implications on insulin cellular communication mediated by EVs. Metabolites. 2022;12:754.
21. Longo A, Manganelli V, Misasi R, et al. Extracellular vesicles in the crosstalk of autophagy and apoptosis: a role for lipid rafts. Cells. 2025;14:749.
22. Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.
23. Rädler J, Gupta D, Zickler A, Andaloussi SE. Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading. Mol Ther. 2023;31:1231-50.
24. Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal. 2021;19:47.
25. Padinharayil H, Varghese J, Wilson C, George A. Mesenchymal stem cell-derived exosomes: characteristics and applications in disease pathology and management. Life Sci. 2024;342:122542.
26. Rather HA, Almousa S, Craft S, Deep G. Therapeutic efficacy and promise of stem cell-derived extracellular vesicles in Alzheimer’s disease and other aging-related disorders. Ageing Res Rev. 2023;92:102088.
27. Sawicki S, Bugno-Poniewierska M, Żurowski J, et al. Comparative transcriptome and microRNA profiles of equine mesenchymal stem cells, fibroblasts, and their extracellular vesicles. Genes. 2025;16:936.
28. Rezaie J, Nejati V, Mahmoodi M, Ahmadi M. Mesenchymal stem cells derived extracellular vesicles: a promising nanomedicine for drug delivery system. Biochem Pharmacol. 2022;203:115167.
29. Yuan X, Sun L, Jeske R, et al. Engineering extracellular vesicles by three-dimensional dynamic culture of human mesenchymal stem cells. J Extracell Vesicles. 2022;11:e12235.
30. Bertolino GM, Maumus M, Jorgensen C, Noël D. Therapeutic potential in rheumatic diseases of extracellular vesicles derived from mesenchymal stromal cells. Nat Rev Rheumatol. 2023;19:682-94.
31. Xiao Y, Hoorain I, Zhang L, et al. Unpacking the anti-fibrotic arsenal: molecular mechanisms and therapeutic translation of MSC-derived exosomes in pulmonary fibrosis. Front Immunol. 2025;16:1725041.
32. Yoo D, Jung SY, Go D, et al. Functionalized extracellular vesicles of mesenchymal stem cells for regenerative medicine. J Nanobiotechnology. 2025;23:219.
33. Li F, Zhang J, Chen A, et al. Combined transplantation of neural stem cells and bone marrow mesenchymal stem cells promotes neuronal cell survival to alleviate brain damage after cardiac arrest via microRNA-133b incorporated in extracellular vesicles. Aging. 2021;13:262-78.
34. Tan Q, Xia D, Ying X. miR-29a in exosomes from bone marrow mesenchymal stem cells inhibit fibrosis during endometrial repair of intrauterine adhesion. Int J Stem Cells. 2020;13:414-23.
35. Wei R, Zhang L, Hu W, Shang X, He Y, Zhang W. Zeb2/axin2-enriched BMSC-derived exosomes promote post-stroke functional recovery by enhancing neurogenesis and neural plasticity. J Mol Neurosci. 2022;72:69-81.
36. Ding Z, Greenberg ZF, Serafim MF, et al. Understanding molecular characteristics of extracellular vesicles derived from different types of mesenchymal stem cells for therapeutic translation. Extracell Vesicle. 2024;3:100034.
37. Abdal Dayem A, Lee SB, Kim K, et al. Production of mesenchymal stem cells through stem cell reprogramming. Int J Mol Sci. 2019;20:1922.
38. Yamanaka S. Pluripotent stem cell-based cell therapy-promise and challenges. Cell Stem Cell. 2020;27:523-31.
39. Shi Y, Yang X, Wang S, et al. Human umbilical cord mesenchymal stromal cell-derived exosomes protect against MCD-induced NASH in a mouse model. Stem Cell Res Ther. 2022;13:517.
40. Zhang Z, Mi T, Jin L, et al. Comprehensive proteomic analysis of exosome mimetic vesicles and exosomes derived from human umbilical cord mesenchymal stem cells. Stem Cell Res Ther. 2022;13:312.
41. Yaghoubi Y, Movassaghpour A, Zamani M, Talebi M, Mehdizadeh A, Yousefi M. Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment. Life Sci. 2019;233:116733.
42. Mazini L, Rochette L, Amine M, Malka G. Regenerative capacity of adipose derived stem cells (ADSCs), comparison with mesenchymal stem cells (MSCs). Int J Mol Sci. 2019;20:2523.
43. Nashwan S, Ismail MA, Saleh T, et al. Comparative analysis of extracellular vesicles from induced and adipose-derived mesenchymal stem cells: implications for regenerative medicine. PLoS One. 2025;20:e0325065.
44. Heo JS, Choi Y, Kim HO. Adipose-derived mesenchymal stem cells promote M2 macrophage phenotype through exosomes. Stem Cells Int. 2019;2019:7921760.
45. Xing X, Han S, Cheng G, Ni Y, Li Z, Li Z. Proteomic analysis of exosomes from adipose-derived mesenchymal stem cells: a novel therapeutic strategy for tissue injury. Biomed Res Int. 2020;2020:6094562.
46. Hong P, Yang H, Wu Y, Li K, Tang Z. The functions and clinical application potential of exosomes derived from adipose mesenchymal stem cells: a comprehensive review. Stem Cell Res Ther. 2019;10:242.
47. Tian L, Zhang D, Wang Z, et al. MiR-877, an exosomal miRNA from mechanical stretch induced adipose derived stromal cells, enhances fracture healing in nonunion rats with type 2 diabetes mellitus. Stem Cell Res Ther. 2025;16:575.
48. Chang LH, Wu SC, Chen CH, et al. Exosomes derived from hypoxia-cultured human adipose stem cells alleviate articular chondrocyte inflammaging and post-traumatic osteoarthritis progression. Int J Mol Sci. 2023;24:13414.
49. Belair C, Sim S, Kim KY, Tanaka Y, Park IH, Wolin SL. The RNA exosome nuclease complex regulates human embryonic stem cell differentiation. J Cell Biol. 2019;218:2564-82.
50. Kwon MH, Song KM, Limanjaya A, et al. Embryonic stem cell-derived extracellular vesicle-mimetic nanovesicles rescue erectile function by enhancing penile neurovascular regeneration in the streptozotocin-induced diabetic mouse. Sci Rep. 2019;9:20072.
51. Cruz L, Arevalo Romero JA, Brandão Prado M, Santos TG, Hohmuth Lopes M. Evidence of extracellular vesicles biogenesis and release in mouse embryonic stem cells. Stem Cell Rev Rep. 2018;14:262-76.
52. Jeske R, Bejoy J, Marzano M, Li Y. Human pluripotent stem cell-derived extracellular vesicles: characteristics and applications. Tissue Eng Part B Rev. 2020;26:129-44.
53. Liu M, Qiu Y, Xue Z, et al. Small extracellular vesicles derived from embryonic stem cells restore ovarian function of premature ovarian failure through PI3K/AKT signaling pathway. Stem Cell Res Ther. 2020;11:3.
54. Wang AYL, Kao HK, Liu YY, Loh CYY. Engineered extracellular vesicles derived from pluripotent stem cells: a cell-free approach to regenerative medicine. Burns Trauma. 2025;13:tkaf013.
55. Fan C, Zhang E, Joshi J, Yang J, Zhang J, Zhu W. Utilization of human induced pluripotent stem cells for cardiac repair. Front Cell Dev Biol. 2020;8:36.
56. Barreca MM, Cancemi P, Geraci F. Mesenchymal and induced pluripotent stem cells-derived extracellular vesicles: the new frontier for regenerative medicine? Cells. 2020;9:1163.
57. Xu M, Chen G, Dong Y, et al. Stable expression of a truncated TLX variant drives differentiation of induced pluripotent stem cells into self-renewing neural stem cells for production of extracellular vesicles. Stem Cell Res Ther. 2022;13:436.
58. Wang Y, Zhao J, Guo Q, et al. Neural stem cell-derived exosomes improve neurite outgrowth and cognitive function through transferring miR-132-3p. Exp Neurol. 2025;388:115224.
59. Yuan P, Ding L, Chen H, et al. Neural stem cell-derived exosomes regulate neural stem cell differentiation through miR-9-Hes1 axis. Front Cell Dev Biol. 2021;9:601600.
60. Derkus B, Isik M, Eylem CC, et al. Xenogenic neural stem cell-derived extracellular nanovesicles modulate human mesenchymal stem cell fate and reconstruct metabolomic structure. Adv Biol. 2022;6:e2101317.
61. Luo H, Ye G, Liu Y, et al. miR-150-3p enhances neuroprotective effects of neural stem cell exosomes after hypoxic-ischemic brain injury by targeting CASP2. Neurosci Lett. 2022;779:136635.
62. Ma K, Xu H, Zhang J, et al. Insulin-like growth factor-1 enhances neuroprotective effects of neural stem cell exosomes after spinal cord injury via an miR-219a-2-3p/YY1 mechanism. Aging. 2019;11:12278-94.
63. Doktor F, Figueira RL, Fortuna V, et al. Amniotic fluid stem cell extracellular vesicles promote lung development via TGF-beta modulation in a fetal rat model of oligohydramnios. J Control Release. 2025;377:427-41.
64. Kim T, Hong JW, Lee LP. Efficient methods of isolation and purification of extracellular vesicles. Nano Converg. 2025;12:45.
65. Li K, Guo B, Gu J, et al. Emerging advances in drug delivery systems (DDSs) for optimizing cancer complications. Mater Today Bio. 2025;30:101375.
66. Ratushnyak MG, Shaposhnikova DA, Gubani DF, Kondratyev KV. Characterization of stem cell exosomes isolated by ultracentrifugation, depth filtration, and precipitation with polyethylene glycol. Nanotechnologies Russ. 2025;20:78-87.
67. Khan MI, Chen K, Zhang L, et al. Efficient purification of exosomes and subpopulations in fresh bovine milk via fine isolation of free-flow isoelectric focusing in large scale. CEJ. 2025;508:160850.
68. Chen S, Shiesh SC, Lee GB, Chen C. Two-step magnetic bead-based (2MBB) techniques for immunocapture of extracellular vesicles and quantification of microRNAs for cardiovascular diseases: a pilot study. PLoS One. 2020;15:e0229610.
69. Kverneland AH, Østergaard O, Emdal KB, Svane IM, Olsen JV. Differential ultracentrifugation enables deep plasma proteomics through enrichment of extracellular vesicles. Proteomics. 2023;23:e2200039.
70. Benmoussa A, Michel S, Gilbert C, Provost P. Isolating multiple extracellular vesicles subsets, including exosomes and membrane vesicles, from bovine milk using sodium citrate and differential ultracentrifugation. Bio Protoc. 2020;10:e3636.
71. Nielsen T, Kristensen AF, Pedersen S, Christiansen G, Kristensen SR. Investigation of procoagulant activity in extracellular vesicles isolated by differential ultracentrifugation. J Extracell Vesicles. 2018;7:1454777.
72. Langevin SM, Kuhnell D, Orr-Asman MA, et al. Balancing yield, purity and practicality: a modified differential ultracentrifugation protocol for efficient isolation of small extracellular vesicles from human serum. RNA Biol. 2019;16:5-12.
73. Musante L, Tataruch-Weinert D, Kerjaschki D, Henry M, Meleady P, Holthofer H. Residual urinary extracellular vesicles in ultracentrifugation supernatants after hydrostatic filtration dialysis enrichment. J Extracell Vesicles. 2017;6:1267896.
74. Soares M, Pinto MM, Nobre RJ, et al. Isolation of extracellular vesicles from human follicular fluid: size-exclusion chromatography versus ultracentrifugation. Biomolecules. 2023;13:278.
75. Foers AD, Chatfield S, Dagley LF, et al. Enrichment of extracellular vesicles from human synovial fluid using size exclusion chromatography. J Extracell Vesicles. 2018;7:1490145.
76. Böing AN, van der Pol E, Grootemaat AE, Coumans FA, Sturk A, Nieuwland R. Single-step isolation of extracellular vesicles by size-exclusion chromatography. J Extracell Vesicles. 2014;3:23430.
77. Jung JH, Back W, Yoon J, et al. Dual size-exclusion chromatography for efficient isolation of extracellular vesicles from bone marrow derived human plasma. Sci Rep. 2021;11:217.
78. Singh M, Tiwari PK, Kashyap V, Kumar S. Proteomics of extracellular vesicles: recent updates, challenges and limitations. Proteomes. 2025;13:12.
79. Yang D, Zhang W, Zhang H, et al. Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics. Theranostics. 2020;10:3684-707.
80. Duong P, Chung A, Bouchareychas L, Raffai RL. Cushioned-density gradient ultracentrifugation (C-DGUC) improves the isolation efficiency of extracellular vesicles. PLoS One. 2019;14:e0215324.
81. Parimon T, Garrett NE 3rd, Chen P, Antes TJ. Isolation of extracellular vesicles from murine bronchoalveolar lavage fluid using an ultrafiltration centrifugation technique. J Vis Exp. 2018;141:e58310.
82. Fortunato D, Giannoukakos S, Giménez-Capitán A, Hackenberg M, Molina-Vila MA, Zarovni N. Selective isolation of extracellular vesicles from minimally processed human plasma as a translational strategy for liquid biopsies. Biomark Res. 2022;10:57.
83. Yang H, Chen J. Bone marrow mesenchymal stem cell-derived exosomes carrying long noncoding RNA ZFAS1 alleviate oxidative stress and inflammation in ischemic stroke by inhibiting microRNA-15a-5p. Metab Brain Dis. 2022;37:2545-57.
84. Liu X, Zhang M, Liu H, et al. Bone marrow mesenchymal stem cell-derived exosomes attenuate cerebral ischemia-reperfusion injury-induced neuroinflammation and pyroptosis by modulating microglia M1/M2 phenotypes. Exp Neurol. 2021;341:113700.
85. Xie X, Cao Y, Dai L, Zhou D. Bone marrow mesenchymal stem cell-derived exosomal lncRNA KLF3-AS1 stabilizes Sirt1 protein to improve cerebral ischemia/reperfusion injury via miR-206/USP22 axis. Mol Med. 2023;29:3.
86. Zhang Z, Ji R, Liu Z, et al. hUMSC-Exosomes suppress TREM1-p38 MAPK signaling via HMGB1-dependent mechanisms to reprogram microglial function and promote neuroprotection in ischemic stroke. J Nanobiotechnology. 2025;23:572.
87. Liu Q, Ma H, Liao J, et al. MiR-125a-5p in extracellular vesicles of neural stem cells acts as a crosstalk signal modulating neuroinflammatory microenvironment to alleviate cerebral ischemia-reperfusion injury. Theranostics. 2025;15:7064-89.
88. Wang J, Zhao M, Fu D, et al. Human neural stem cell-derived extracellular vesicles protect against ischemic stroke by activating the PI3K/AKT/mTOR pathway. Neural Regen Res. 2025;20:3245-58.
89. Wang QS, Xiao RJ, Peng J, Yu ZT, Fu JQ, Xia Y. Bone marrow mesenchymal stem cell-derived exosomal KLF4 alleviated ischemic stroke through inhibiting N6-methyladenosine modification level of Drp1 by targeting lncRNA-ZFAS1. Mol Neurobiol. 2023;60:3945-62.
90. Cui GH, Guo HD, Li H, et al. RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer’s disease. Immun Ageing. 2019;16:10.
91. Liu S, Fan M, Xu JX, et al. Exosomes derived from bone-marrow mesenchymal stem cells alleviate cognitive decline in AD-like mice by improving BDNF-related neuropathology. J Neuroinflammation. 2022;19:35.
92. Ding M, Shen Y, Wang P, et al. Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial activation in Alzheimer’s disease. Neurochem Res. 2018;43:2165-77.
93. Losurdo M, Pedrazzoli M, D’Agostino C, et al. Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer’s disease. Stem Cells Transl Med. 2020;9:1068-84.
94. Li B, Chen Y, Zhou Y, et al. Neural stem cell-derived exosomes promote mitochondrial biogenesis and restore abnormal protein distribution in a mouse model of Alzheimer’s disease. Neural Regen Res. 2024;19:1593-601.
95. Zhang L, Zhan M, Sun H, et al. Mesenchymal stem-cell-derived exosomes loaded with phosphorus dendrimers and quercetin treat Parkinson’s disease by modulating inflammatory immune microenvironment. ACS Appl Mater Interfaces. 2025;17:32013-27.
96. Cai Y, Zhang MM, Wang M, Jiang ZH, Tan ZG. Bone marrow-derived mesenchymal stem cell-derived exosomes containing gli1 alleviate microglial activation and neuronal apoptosis in vitro and in a mouse Parkinson disease model by direct inhibition of Sp1 signaling. J Neuropathol Exp Neurol. 2022;81:522-34.
97. Zhang ZX, Zhou YJ, Gu P, et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate Parkinson’s disease and neuronal damage through inhibition of microglia. Neural Regen Res. 2023;18:2291-300.
98. Lee EJ, Choi Y, Lee HJ, Hwang DW, Lee DS. Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies. J Nanobiotechnology. 2022;20:198.
99. Yang X, Yang X, Sun A, Chen S, Wang X, Zhao X. The miR-23b-3p from adipose-derived stem cell exosomes alleviate inflammation in mice experiencing kainic acid-induced epileptic seizures. Neuroreport. 2024;35:612-20.
100. Derisfard F, Jafarinezhad Z, Azarpira N, Namavar MR, Aligholi H. Exosomes obtained from human adipose-derived stem cells alleviate epileptogenesis in the pentylenetetrazol model of epilepsy. Neuroreport. 2025;36:161-8.
101. Che J, Wang H, Dong J, et al. Human umbilical cord mesenchymal stem cell-derived exosomes attenuate neuroinflammation and oxidative stress through the NRF2/NF-κB/NLRP3 pathway. CNS Neurosci Ther. 2024;30:e14454.
102. Niu Y, Wang X, Li M, Niu B. Exosomes from human umbilical cord Mesenchymal stem cells attenuates stress-induced hippocampal dysfunctions. Metab Brain Dis. 2020;35:1329-40.
103. Ma L, Xiao C, Zhang Z, Zhan YA. Exosomes secreted from induced pluripotent stem cell ameliorate the lipopolysaccharide induced neuroinflammatory response via lncRNA-0949. Immun Inflamm Dis. 2024;12:e1155.
104. Zhong XL, Huang Y, Du Y, et al. Unlocking the therapeutic potential of exosomes derived from nasal olfactory mucosal mesenchymal stem cells: restoring synaptic plasticity, neurogenesis, and neuroinflammation in schizophrenia. Schizophr Bull. 2024;50:600-14.
105. Li P, Zhang F, Huang C, et al. Exosomes derived from DPA-treated UCMSCs attenuated depression-like behaviors and neuroinflammation in a model of depression induced by chronic stress. J Neuroimmune Pharmacol. 2024;19:55.
106. Sun S, Rong J, Wang C, et al. Intranasal administration of exosomes derived from adipose mesenchymal stem cells ameliorates depressive-like behaviors and inhibits inflammation via AMPK/mTOR-mediated autophagy. J Affect Disord. 2025;382:227-47.
107. Zhao M, Wang J, Zhu S, et al. Human neural stem cell-derived exosomes activate PINK1/Parkin pathway to protect against oxidative stress-induced neuronal injury in ischemic stroke. J Transl Med. 2025;23:402.
108. Guo H, Huang B, Wang Y, Zhang Y, Ma Q, Ren Y. Bone marrow mesenchymal stem cells-derived exosomes improve injury of hippocampal neurons in rats with depression by upregulating microRNA-26a expression. Int Immunopharmacol. 2020;82:106285.
109. Abdel-Gawad DRI, Khalil F, Shehata O, et al. Role of bone marrow mesenchymal stem cell-derived exosomes in reducing neurotoxicity and depression-like behaviors induced by doxorubicin in rats. Toxicol Res. 2024;13:tfae159.
110. Kuang Y, Zheng X, Zhang L, et al. Adipose-derived mesenchymal stem cells reduce autophagy in stroke mice by extracellular vesicle transfer of miR-25. J Extracell Vesicles. 2020;10:e12024.
111. Wang Y, Niu H, Li L, et al. Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760-3p in cerebral ischemia/reperfusion injury mice inhibiting neuron ferroptosis. J Nanobiotechnology. 2023;21:109.
112. Ye YC, Chang ZH, Wang P, et al. Infarct-preconditioning exosomes of umbilical cord mesenchymal stem cells promoted vascular remodeling and neurological recovery after stroke in rats. Stem Cell Res Ther. 2022;13:378.
113. Ebrahim N, Al Saihati HA, Alali Z, et al. Exploring the molecular mechanisms of MSC-derived exosomes in Alzheimer’s disease: autophagy, insulin and the PI3K/Akt/mTOR signaling pathway. Biomed Pharmacother. 2024;176:116836.
114. Wang X, Yang G. Bone marrow mesenchymal stem cells-derived exosomes reduce Aβ deposition and improve cognitive function recovery in mice with Alzheimer’s disease by activating sphingosine kinase/sphingosine-1-phosphate signaling pathway. Cell Biol Int. 2021;45:775-84.
115. Chen YA, Lu CH, Ke CC, et al. Mesenchymal stem cell-derived exosomes ameliorate Alzheimer's disease pathology and improve cognitive deficits. Biomedicines. 2021;9:594.
116. Huang D, Zhang M, Tan Z. Bone marrow stem cell-exo-derived TSG-6 attenuates 1-methyl-4-phenylpyridinium+-induced neurotoxicity via the STAT3/miR-7/NEDD4/LRRK2 axis. J Neuropathol Exp Neurol. 2022;81:621-34.
117. Guo L, Lv N, Ji JL, et al. Circular RNA hsa_circ_0000288 protects against epilepsy in mice by binding to and stabilizing caprin1 protein. Acta Pharmacol Sin. 2025;46:1592-609.
118. Nazari S, Pourmand SM, Motevaseli E, Hassanzadeh G. Mesenchymal stem cells (MSCs) and MSC-derived exosomes in animal models of central nervous system diseases: Targeting the NLRP3 inflammasome. IUBMB Life. 2023;75:794-810.
119. Tsivion-Visbord H, Perets N, Sofer T, et al. Mesenchymal stem cells derived extracellular vesicles improve behavioral and biochemical deficits in a phencyclidine model of schizophrenia. Transl Psychiatry. 2020;10:305.
120. Liu H, Yan XJ, Hu JL, Pan H, Mao X, Cheng Y. Exosome derived from bone marrow derived mesenchymal stem cells prevents LPS-induced depressive like behaviors. Brain Res Bull. 2025;231:111527.
121. Upadhya R, Madhu LN, Attaluri S, et al. Extracellular vesicles from human iPSC-derived neural stem cells: miRNA and protein signatures, and anti-inflammatory and neurogenic properties. J Extracell Vesicles. 2020;9:1809064.
122. Fu W, Guo Y, Wu P, et al. hADMSC-Evs attenuates depressive and anxiety - like behaviors in chronic liver disease via suppressing Liver-Brain Galectin3 signaling. Brain Behav Immun. 2025;130:106082.
123. Lin SL, Chang YW, Lee W, et al. Role of STAT3-FOXO3 signaling in the modulation of neuroplasticity by PD-L1-HGF-decorated mesenchymal stem cell-derived exosomes in a murine stroke model. Adv Sci. 2024;11:e2404882.
124. Gregorius J, Wang C, Stambouli O, et al. Small extracellular vesicles obtained from hypoxic mesenchymal stromal cells have unique characteristics that promote cerebral angiogenesis, brain remodeling and neurological recovery after focal cerebral ischemia in mice. Basic Res Cardiol. 2021;116:40.
125. Hu H, Hu X, Li L, et al. Exosomes derived from bone marrow mesenchymal stem cells promote angiogenesis in ischemic stroke mice via upregulation of miR-21-5p. Biomolecules. 2022;12:883.
126. Li Y, Liu B, Zhao T, et al. Comparative study of extracellular vesicles derived from mesenchymal stem cells and brain endothelial cells attenuating blood-brain barrier permeability via regulating Caveolin-1-dependent ZO-1 and Claudin-5 endocytosis in acute ischemic stroke. J Nanobiotechnology. 2023;21:70.
127. Liu Y, Huber CC, Wang H. Disrupted blood-brain barrier in 5×FAD mouse model of Alzheimer’s disease can be mimicked and repaired in vitro with neural stem cell-derived exosomes. Biochem Biophys Res Commun. 2020;525:192-6.
128. Qiu L, Cai Y, Geng Y, et al. Mesenchymal stem cell-derived extracellular vesicles attenuate tPA-induced blood-brain barrier disruption in murine ischemic stroke models. Acta Biomater. 2022;154:424-42.
129. Sha S, Shen X, Cao Y, Qu L. Mesenchymal stem cells-derived extracellular vesicles ameliorate Alzheimer's disease in rat models via the microRNA-29c-3p/BACE1 axis and the Wnt/β-catenin pathway. Aging. 2021;13:15285-306.
130. Elia CA, Tamborini M, Rasile M, et al. Intracerebral injection of extracellular vesicles from mesenchymal stem cells exerts reduced Aβ plaque burden in early stages of a preclinical model of Alzheimer’s disease. Cells. 2019;8:1059.
131. Chen H, Huang Z, Lei A, Yu X, Shen M, Wu D. miRNA-211-5p inhibition enhances the protective effect of hucMSC-derived exosome in Aβ1-40 -induced SH-SY5Y cells by increasing NEP expression. J Biochem Mol Toxicol. 2024;38:e23624.
132. Ramalingam M, Jang S, Hwang J, Cho HH, Kim BC, Jeong HS. Neural-induced human adipose tissue-derived stem cell secretome exerts neuroprotection against rotenone-induced Parkinson's disease in rats. Stem Cell Res Ther. 2025;16:193.
133. Guo X, Xing J, Shi X, Cao Y, An L. Effects of neural stem cell-derived exosomes on MPTP-induced Parkinson’s disease in mice. Naturwissenschaften. 2025;112:53.
134. Wang H, Liu Y, Li J, et al. Tail-vein injection of MSC-derived small extracellular vesicles facilitates the restoration of hippocampal neuronal morphology and function in APP / PS1 mice. Cell Death Discov. 2021;7:230.
135. Huang X, Liu X, Zeng J, Du P, Huang X, Lin J. Bone marrow mesenchymal stem cell-derived exosomal microRNA regulates microglial polarization. PeerJ. 2023;11:e16359.
136. Geng Y, Long X, Zhang Y, et al. FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA. J Transl Med. 2023;21:652.
137. Costa-Ferro ZSM, Cunha RS, Rossi EA, et al. Extracellular vesicles derived from mesenchymal stem cells alleviate depressive-like behavior in a rat model of chronic stress. Life Sci. 2025;366-367:123479.
138. Website ClinicalTrials.gov Home Page. Available from https://clinicaltrials.gov/ [accessed 22 May 2026].
139. Xie X, Song Q, Dai C, et al. Clinical safety and efficacy of allogenic human adipose mesenchymal stromal cells-derived exosomes in patients with mild to moderate Alzheimer’s disease: a phase I/II clinical trial. Gen Psychiatr. 2023;36:e101143.
140. Thakur A, Rai D. Global requirements for manufacturing and validation of clinical grade extracellular vesicles. J Liq Biopsy. 2024;6:100278.
141. Kim EH, Son JP, Oh GS, et al. Clinical scale MSC-derived extracellular vesicles enhance poststroke neuroplasticity in rodents and non-human primates. J Extracell Vesicles. 2025;14:e70110.
142. Claridge B, Lozano J, Poh QH, Greening DW. Development of extracellular vesicle therapeutics: challenges, considerations, and opportunities. Front Cell Dev Biol. 2021;9:734720.
143. Ciullo A, Li C, Li L, et al. Biodistribution of unmodified cardiosphere-derived cell extracellular vesicles using single RNA tracing. J Extracell Vesicles. 2022;11:e12178.
144. Zhang T, Zhang L, Ma X, Song W. The tiny giants of regeneration: MSC-derived extracellular vesicles as next-generation therapeutics. Front Cell Dev Biol. 2025;13:1612589.
145. Wiklander OP, Nordin JZ, O’Loughlin A, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4:26316.
146. Silva AKA, Morille M, Piffoux M, et al. Development of extracellular vesicle-based medicinal products: a position paper of the group “Extracellular Vesicle translatiOn to clinicaL perspectiVEs - EVOLVE France”. Adv Drug Deliv Rev. 2021;179:114001.
147. de Almeida Fuzeta M, Gonçalves PP, Fernandes-Platzgummer A, Cabral JMS, Bernardes N, da Silva CL. From promise to reality: bioengineering strategies to enhance the therapeutic potential of extracellular vesicles. Bioengineering. 2022;9:675.
148. Reiner AT, Witwer KW, van Balkom BWM, et al. Concise review: developing best-practice models for the therapeutic use of extracellular vesicles. Stem Cells Transl Med. 2017;6:1730-9.
149. Tan F, Li X, Wang Z, Li J, Shahzad K, Zheng J. Clinical applications of stem cell-derived exosomes. Signal Transduct Target Ther. 2024;9:17.
